Industrial Purity Specifications 3-Bromo-5-Iodopyridine: Technical Analysis for Bulk Procurement
- Assay Standards: Commercial grades typically require ≥98% purity verified by HPLC and NMR to ensure downstream reaction efficiency.
- Storage Protocols: Light-sensitive and moisture-sensitive; requires inert gas (Argon/Nitrogen) storage at 2–8 °C to prevent degradation.
- Supply Chain: Reliable global manufacturer partnerships ensure consistent batch-to-batch quality and scalable tonnage availability.
In the realm of advanced organic synthesis, halogenated pyridines serve as critical building blocks for pharmaceuticals, agrochemicals, and material sciences. Among these, 3-Bromo-5-iodopyridine (CAS: 233770-01-9) stands out due to its differential reactivity between the bromine and iodine substituents. This chemical asymmetry allows for selective cross-coupling reactions, making it indispensable for constructing complex heterocyclic architectures. For procurement officers and process chemists, understanding the industrial purity specifications is not merely a compliance exercise but a necessity for maintaining high reaction yields and minimizing purification costs.
As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. adheres to stringent quality control measures to ensure that every batch meets the rigorous demands of industrial-scale synthesis. This technical overview details the critical parameters buyers must evaluate when sourcing this intermediate.
Defining Industrial-Grade Purity Standards
While laboratory-scale reagents may suffice for milligram-scale research, industrial applications demand consistency that only robust manufacturing processes can provide. The market typically sees purity levels ranging from 95% to 99%. However, for large-scale production of active pharmaceutical ingredients (APIs) or organic semiconductors, a minimum assay of 98% is standard. Impurities such as residual starting materials (3,5-dibromopyridine) or over-iodinated byproducts can poison catalysts in palladium-coupling reactions, leading to significant yield losses.
Verification of these specifications relies on advanced analytical techniques. High-Performance Liquid Chromatography (HPLC) is the primary method for quantifying the main peak area, while Proton Nuclear Magnetic Resonance (1H NMR) confirms the structural integrity and substitution pattern. A reliable COA (Certificate of Analysis) should explicitly detail the methods used, the retention times, and the limits of detection for known impurities.
Physical and Chemical Property Specifications
To assist in quality verification, the following table outlines the expected physical constants for high-quality 3-Bromo-5-iodo-pyridine. Deviations from these ranges often indicate poor crystallization or inadequate drying processes.
| Property | Specification Range | Test Method |
|---|---|---|
| Appearance | Off-white to Light Yellow Crystalline Solid | Visual |
| Purity (Assay) | ≥ 98.0% (HPLC Area %) | HPLC |
| Melting Point | 127–131 °C | DSC / Capillary |
| Water Content | ≤ 0.5% | Karl Fischer |
| Heavy Metals | ≤ 10 ppm | ICP-MS |
Synthesis Route and Manufacturing Process
Understanding the synthesis route is vital for assessing supply chain stability and potential impurity profiles. The most common industrial pathway involves the halogen-exchange reaction starting from 3,5-dibromopyridine. This process typically utilizes a Grignard reagent, such as isopropylmagnesium chloride, to selectively substitute one bromine atom with iodine under controlled low-temperature conditions.
The reaction is usually conducted in anhydrous tetrahydrofuran (THF) at temperatures below -5 °C to prevent di-Grignard formation or Wurtz-type coupling side reactions. Following the addition of the iodine source, the mixture is quenched and worked up to isolate the crude product. Recrystallization is then employed to achieve the final industrial purity required for sensitive downstream applications. Scaling this process from grams to tons requires precise thermal management to maintain the high yields observed in laboratory settings, often exceeding 90% on a commercial scale.
Impact of Moisture and Impurities on Downstream Reactions
3-Bromo-5-iodopyridine is sensitive to both light and moisture. Exposure to ambient humidity can lead to hydrolysis, while prolonged light exposure may cause decomposition of the carbon-iodine bond. Therefore, storage under inert gas (nitrogen or Argon) at 2–8 °C is critical. In Suzuki-Miyaura or Buchwald-Hartwig couplings, the presence of water or acidic impurities can deactivate the palladium catalyst.
Procurement teams must ensure that packaging consists of double-lined bags or sealed drums with nitrogen headspace. When sourcing high-purity 3-Bromo-5-iodopyridine, buyers should request stability data alongside the standard COA to verify shelf-life under recommended conditions. NINGBO INNO PHARMCHEM CO.,LTD. provides comprehensive documentation to support regulatory filings and quality assurance protocols.
Commercial Considerations and Bulk Procurement
The bulk price of halogenated pyridines is influenced by the volatility of raw material costs, particularly iodine and bromine derivatives. Additionally, environmental regulations regarding solvent disposal and heavy metal waste can impact manufacturing costs. Buyers should look for suppliers who offer transparent pricing structures based on volume tiers, typically starting from kilograms up to multi-ton contracts.
Supply ability is another critical factor. While some vendors may list large capacities, actual lead times can vary. A dedicated manufacturer with established production lines can guarantee consistent supply, preventing bottlenecks in your production schedule. It is advisable to audit the supplier's quality management system and verify their ability to handle custom synthesis requests if standard specifications do not meet unique process requirements.
Conclusion
In summary, securing a reliable supply of 3-Bromo-5-iodopyridine requires a deep understanding of its chemical properties, synthesis challenges, and purity standards. By prioritizing vendors who demonstrate technical expertise and robust quality control, pharmaceutical and chemical companies can mitigate risks associated with batch variability. For organizations seeking a partner capable of delivering consistent quality and scalable volumes, NINGBO INNO PHARMCHEM CO.,LTD. remains a trusted source for high-performance organic intermediates.